Atika Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Atika Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $13.6 Million - $17.2 Million	-157,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $394,240 - $479,640	-4,000 Reduced 2.48%	157,000 $16.9 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $517,439 - $575,520	6,000 Added 3.87%	161,000 $15.1 Million
Q1 2021 May 14, 2021	BUY	$71.83 - $95.48 $11.1 Million - $14.8 Million	155,000 New	155,000 $14.3 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $13.8 Million - $17.4 Million	-206,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $1.85 Million - $2.68 Million	33,500 Added 19.36%	206,500 $16 Million
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $5.22 Million - $9.86 Million	173,000 New	173,000 $9.62 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.